CN Stock MarketDetailed Quotes
300199 Hybio Pharmaceutical
- 12.82
- -0.59-4.40%
Market Closed Dec 13 15:00 CST
11.32BMarket Cap-30.74P/E (TTM)
13.30High12.82Low342.25KlotVolume13.30Open13.41Pre Close445.74MTurnover4.85%Turnover RatioLossP/E (Static)883.24MShares15.0252wk High16.03P/B9.05BFloat Cap8.8352wk Low16.09Limit Up706.28MShs Float52.44Historical High10.73Limit Down3.58%Amplitude2.39Historical Low--Dividend TTM13.02Avg Price197.30KlotAsk--Div YieldTTM100Lot Size135.50KlotBid
Hybio Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 0.64%440.14M | -15.38%275.26M | -22.94%130.54M | -16.45%603.75M | -15.50%437.35M | -9.22%325.29M | -13.17%169.38M | -9.18%722.65M | -13.61%517.56M | -12.73%358.31M |
| Refunds of taxes and levies | -21.42%6.17M | -55.55%3.39M | 482.77%2.33M | -73.67%8.9M | -76.07%7.85M | -76.24%7.62M | -9.38%400K | 2,743.81%33.8M | 3,814.98%32.8M | 4,285.71%32.08M |
| Cash received relating to other operating activities | 23.96%55.53M | -24.79%27.34M | -10.44%24.11M | 77.66%52.01M | 44.26%44.8M | 71.04%36.35M | 425.95%26.92M | -69.22%29.28M | -68.74%31.05M | -52.44%21.26M |
| Cash inflows from operating activities | 2.42%501.84M | -17.14%305.98M | -20.20%156.97M | -15.41%664.66M | -15.72%490M | -10.30%369.26M | -1.96%196.7M | -11.91%785.72M | -16.85%581.41M | -9.73%411.65M |
| Goods services cash paid | 33.51%109.47M | 3.33%66.55M | -30.07%30.23M | 5.42%106.65M | 40.06%82M | 74.48%64.41M | 144.92%43.22M | 40.80%101.16M | 24.58%58.54M | 11.90%36.91M |
| Staff behalf paid | -15.86%107.78M | -26.40%68.09M | -35.27%35.54M | 6.64%163.63M | 10.28%128.1M | 10.57%92.52M | 9.39%54.9M | 9.30%153.44M | 7.98%116.16M | 12.65%83.67M |
| All taxes paid | -57.85%24.21M | -59.82%17.47M | -79.76%5.5M | -9.03%68.58M | 6.30%57.43M | 13.79%43.47M | 42.70%27.19M | 13.69%75.39M | 22.42%54.03M | 34.25%38.2M |
| Cash paid relating to other operating activities | -37.74%172.31M | -41.47%120.89M | -35.20%70.56M | -25.14%329.33M | -19.70%276.78M | -6.84%206.53M | 17.06%108.89M | -3.66%439.92M | -7.03%344.71M | -2.26%221.7M |
| Cash outflows from operating activities | -23.98%413.77M | -32.91%273M | -39.44%141.82M | -13.21%668.2M | -5.08%544.3M | 6.95%406.92M | 30.18%234.2M | 4.73%769.92M | 0.69%573.44M | 4.95%380.48M |
| Net cash flows from operating activities | 262.17%88.07M | 187.58%32.98M | 140.41%15.15M | -122.37%-3.54M | -780.88%-54.31M | -220.82%-37.66M | -281.02%-37.5M | -89.92%15.81M | -93.85%7.98M | -66.65%31.17M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | ---- | ---- | -6.84%228.52M | 60.05%228.52M | 84.50%195.29M | 34.89%44.27M | 926.32%245.29M | 12,317.94%142.78M | 9,107.79%105.85M |
| Cash received from returns on investments | 1,690.18%614.7K | --614.7K | --614.7K | -95.79%34.34K | --34.34K | ---- | ---- | -74.46%815.05K | ---- | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 6,746.02%45.53M | 31,228.28%45.43M | 6.50%426K | -97.74%1.07M | -98.09%665K | -99.57%145K | -98.70%400K | 34,816.07%47.49M | 25,500.26%34.82M | 24,898.68%34M |
| Cash inflows from investing activities | -79.87%46.14M | -76.44%46.04M | -97.67%1.04M | -21.79%229.62M | 29.07%229.22M | 39.75%195.44M | -29.79%44.67M | 978.29%293.6M | 3,866.63%177.59M | 9,232.95%139.85M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -3.89%70.22M | -33.66%42.71M | -46.25%17.45M | -56.93%81.76M | -51.64%73.06M | -5.63%64.38M | 19.84%32.47M | -4.60%189.85M | -13.85%151.07M | -34.18%68.22M |
| Cash paid to acquire investments | 3,000.00%4.65M | 2,566.67%4M | ---- | -99.70%150K | --150K | --150K | ---- | 1,751.85%50M | ---- | ---- |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -97.45%100K | 1,179.39%50.1M | 1,179.39%50.1M |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.93M | --1.93M | --1.93M |
| Cash outflows from investing activities | 2.27%74.87M | -27.61%46.71M | -46.25%17.45M | -66.13%81.91M | -63.95%73.21M | -46.34%64.53M | -43.23%32.47M | 17.64%241.88M | 13.11%203.1M | 11.48%120.25M |
| Net cash flows from investing activities | -118.41%-28.73M | -100.51%-668.91K | -234.49%-16.41M | 185.62%147.71M | 711.59%156.01M | 568.09%130.91M | 89.89%12.2M | 128.99%51.72M | 85.43%-25.51M | 118.42%19.59M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --2.24M | --2.14M | --2.14M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | --2.14M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from bonds issue | ---- | ---- | ---- | --296.5M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | 134.10%1.04B | 279.34%661.43M | 309.64%202.22M | 105.01%1.02B | 35.22%444.87M | 89.33%174.37M | 208.20%49.37M | -65.72%499.24M | -74.83%328.99M | -91.07%92.1M |
| Cash received relating to other financing activities | 242.34%197.66M | 6,467.45%181.33M | 7,837.35%111.4M | 61.99%69.74M | 55.99%57.74M | -64.23%2.76M | -80.11%1.4M | -39.65%43.05M | -2.36%37.01M | --7.72M |
| Cash inflows from financing activities | 146.98%1.24B | 377.00%844.91M | 521.95%315.77M | 156.27%1.39B | 37.32%502.6M | 77.45%177.13M | 120.04%50.77M | -64.97%542.29M | -73.19%366M | -90.51%99.82M |
| Borrowing repayment | 133.74%1.21B | 277.36%889.95M | 2,420.95%515.95M | 131.97%1.11B | 64.42%516.12M | 310.54%235.83M | 64.01%20.47M | -70.65%478.97M | -78.46%313.91M | -95.05%57.45M |
| Dividend interest payment | -0.79%76.1M | 6.13%49.21M | 23.69%28.48M | 2.70%117.9M | 8.35%76.71M | 0.94%46.37M | -0.01%23.02M | -0.73%114.8M | 33.62%70.8M | 25.94%45.94M |
| Cash payments relating to other financing activities | 268.02%224.69M | 3,762.51%212.35M | 1,259.86%70.34M | 230.74%64.89M | 260.20%61.05M | -42.21%5.5M | -22.36%5.17M | -63.85%19.62M | 101.66%16.95M | -67.49%9.51M |
| Cash outflows from financing activities | 130.50%1.51B | 300.25%1.15B | 1,163.34%614.77M | 110.93%1.29B | 62.80%653.88M | 154.84%287.7M | 15.41%48.66M | -65.95%613.39M | -73.55%401.66M | -90.80%112.89M |
| Net cash flows from financing activities | -75.73%-265.85M | -177.30%-306.6M | -14,285.00%-299M | 234.79%95.85M | -324.25%-151.28M | -745.45%-110.57M | 111.04%2.11M | 71.97%-71.11M | 76.77%-35.66M | 92.54%-13.08M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 244.90%2M | 216.87%1.89M | 325.12%412.51K | -55.38%923.28K | -74.70%579.51K | -44.31%596.19K | -763.20%-183.23K | 230.64%2.07M | 301.20%2.29M | 190.89%1.07M |
| Net increase in cash and cash equivalents | -317.37%-204.51M | -1,528.81%-272.4M | -1,182.91%-299.85M | 16,007.66%240.94M | 3.73%-49M | -143.15%-16.72M | -391.12%-23.37M | 99.45%-1.51M | 74.54%-50.9M | 120.45%38.76M |
| Add:Begin period cash and cash equivalents | 243.39%339.94M | 243.39%339.94M | 243.39%339.94M | -1.51%98.99M | -1.51%98.99M | -1.51%98.99M | -1.51%98.99M | -73.36%100.51M | -73.36%100.51M | -73.36%100.51M |
| End period cash equivalent | 170.89%135.43M | -17.91%67.54M | -46.99%40.09M | 243.39%339.94M | 0.78%49.99M | -40.93%82.27M | -30.33%75.62M | -1.51%98.99M | -72.03%49.61M | -25.85%139.27M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
